Skip to main content
. 2018 Nov 16;10:139–152. doi: 10.2147/HMER.S180246

Table 4.

Proportion of survivors on days 28 and 84

Treatment Alive (no transplant) Liver transplant Death Total
Day 28
ELAD 26 (81.2%) 1 (3.1%) 4 (12.5%) 32a
Control 8 (47.1%) 5 (29.4%) 3 (17.6%) 17a
Day 84
ELAD 21 (65.6%) 1 (3.1%) 9 (28.1%) 32a
Control 7 (41.2%) 5 (29.4%) 4 (23.5%) 17a

Note:

a

One subject in each group withdrew consent.